Home LiteratureArticle Details
PMID: 16950012 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries.

Vaccine ·Vol. 24 Suppl 3 ·2006-08-31 ·Pages S3/233-41

Lehtinen M, Herrero R, Mayaud P, Barnabas R, Dillner J, Paavonen J, Smith PG

Abstract

We review studies of the implementation of human papillomavirus (HPV) vaccination programmes in developed and developing countries. The review spans the period from establishment of long-term vaccine efficacy follow-up studies, operational research on issues of vaccine preparedness, and relevant predictive modelling studies during the pre-licensure phase to plans of phase IV effectiveness trials, forms of epidemiological surveillance, and further operational research in the post-licensure phase. Much of the research is already ongoing. Depending on the results of the planned immuno bridging studies among HIV-negative and HIV-positive women, further phase III and/or phase IV trials may be warranted.

MeSH Terms
Developed Countries Developing Countries Humans Papillomavirus Infections/prevention & control Papillomavirus Vaccines/immunology Product Surveillance, Postmarketing Research/trends
Chemicals
Papillomavirus Vaccines
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Lehtinen Matti
National Public Health Institute, Department of Infectious Disease Epidemiology, KTL, Oulu, Finland. Matti.Lehtinen@uta.fi
Herrero Rolando
Mayaud Philippe
Barnabas Ruanne
Dillner Joakim
Paavonen Jorma
Smith Peter G
Article Info
Journal
Vaccine
Abbr.
Vaccine
ISSN
0264-410X
Published
2006-08-31
Pages
S3/233-41
Language
English
Region
Netherlands
NLM ID
8406899
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com